You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

COM701

Showing 1 - 25 of 1,186
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Cancer, Ovarian Cancer, Lung Cancer Trial in United States (Dose escalation: COM902 monotherapy., Evaluation of

Recruiting
  • Advanced Cancer
  • +6 more
  • Dose escalation: COM902 monotherapy.
  • +3 more
  • Grand Rapids, Michigan
  • +5 more
Aug 8, 2022

Endometrial Tumors, Ovarian Cancer, Solid Tumor Trial in United States (COM701 in combination with BMS-986207 and nivolumab.)

Recruiting
  • Endometrial Neoplasms
  • +3 more
  • COM701 in combination with BMS-986207 and nivolumab.
  • Chicago, Illinois
  • +8 more
Aug 8, 2022

Advanced Cancer, Ovarian Cancer, Breast Cancer Trial in United States (COM701, COM701 with Opdivo (Nivolumab).)

Recruiting
  • Advanced Cancer
  • +9 more
  • COM701
  • COM701 with Opdivo (Nivolumab).
  • Los Angeles, California
  • +10 more
Jan 25, 2022

Ectonucleotide Pyrophosphatase/Phosphodiesterase1 Deficiency, Autosomal Recessive Hypophosphatemic Rickets, Generalized Arterial

Not yet recruiting
  • Ectonucleotide Pyrophosphatase/Phosphodiesterase1 Deficiency
  • +2 more
  • INZ-701
  • Control Arm (Conventional Therapy)
  • (no location specified)
Sep 18, 2023

Hypertension Trial (CKD-828, D064, D701)

Not yet recruiting
  • Hypertension
  • CKD-828, D064, D701
  • (no location specified)
Apr 18, 2023

Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency, Autosomal Recessive Hypophosphatemic Rickets, Generalized Arterial

Not yet recruiting
  • Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency
  • +2 more
  • (no location specified)
Feb 15, 2023

Cystic Fibrosis, Cystic Fibrosis Pulmonary Exacerbation Trial (Sodium Fusidate, Placebo)

Not yet recruiting
  • Cystic Fibrosis
  • Cystic Fibrosis Pulmonary Exacerbation
  • Sodium Fusidate
  • Placebo
  • (no location specified)
Dec 14, 2022

Hypertension Trial (D064+D701, CKD-828 Formulation 1, CKD-828 Formulation 2)

Not yet recruiting
  • Hypertension
  • (no location specified)
Sep 13, 2022

Malignant Pleural Effusions, NSCLC Stage IV Trial in Hangzhou (M701 pleural infusion, Pleural drainage, Cisplatin pleural

Not yet recruiting
  • Malignant Pleural Effusions
  • NSCLC Stage IV
  • M701 pleural infusion
  • +2 more
  • Hangzhou, Zhejiang, China
    Cancer Hospital of the University of Chinese Academy of Sciences
Sep 14, 2022

Wilson Disease Trial in Spain, United States (genetic, other, drug)

Recruiting
  • Wilson Disease
  • UX701
  • +3 more
  • Los Angeles, California
  • +11 more
Jul 22, 2022

Anesthesia, General Trial in Seoul (1-min interval oscillometric method, arterial catheterization method)

Not yet recruiting
  • Anesthesia, General
  • 1-min interval oscillometric method
  • arterial catheterization method
  • Seoul, Korea, Republic of
  • +1 more
Mar 18, 2023

Myopia Trial in Ho Chi Minh City (Myatro, Myatro XL)

Not yet recruiting
  • Myopia
  • Ho Chi Minh City, Vietnam
    University Medical Center HCMC
Apr 5, 2023

Relapsed/Refractory Multiple Myeloma Trial (AMG 701)

Not yet recruiting
  • Relapsed/Refractory Multiple Myeloma
  • AMG 701
  • (no location specified)
Jun 6, 2022

Lung Tumor, NSCLC, Respiratory Tract Tumors Trial in United States (BLU-701, osimertinib, carboplatin)

Recruiting
  • Lung Neoplasm
  • +26 more
  • Boston, Massachusetts
  • +6 more
Jun 23, 2022

Flap Thickness Versus Pre-determined Surgical Planning Using

Recruiting
  • Myopia
  • WaveLight® FS200 femtosecond laser
  • Bismarck, North Dakota
    Bismarck Lasik
Aug 12, 2022

Four Intensive Care Scores in Prediction of VA-ECMO Survival.

Recruiting
  • Cardiogenic Shock
  • Extracorporeal Membrane Oxygenation Complication
  • ECMO
  • Doha, DA, Qatar
    Hamad medical corporation
Feb 15, 2023

Melioidosis Trial in Udon Thani (Ceftazidime or meropenem, ARV-1801, Placebo)

Recruiting
  • Melioidosis
  • Ceftazidime or meropenem
  • +2 more
  • Nai Muang, Thailand
  • +4 more
Nov 29, 2022

Trial (AMG 701)

Available
    • AMG 701
    • (no location specified)
    Feb 15, 2022

    ATP-Binding Cassette Subfamily C Member 6 Deficiency, Pseudoxanthoma Elasticum, Generalized Arterial Calcification of Infancy

    Recruiting
    • ATP-Binding Cassette Subfamily C Member 6 Deficiency
    • +2 more
    • Eatontown, New Jersey
    • +1 more
    Jan 12, 2022

    Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency, Autosomal Recessive Hypophosphatemic Rickets, Generalized Arterial

    Recruiting
    • Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency
    • +2 more
    • Rochester, Minnesota
    • +2 more
    Jan 4, 2022

    Cardiovascular Abnormalities, Vascular Diseases, Retinal Vascular Trial (Ophthalmologic consultation)

    Not yet recruiting
    • Cardiovascular Abnormalities
    • +2 more
    • Ophthalmologic consultation
    • (no location specified)
    Nov 21, 2022

    Psoriasis Trial in Fargo, Philadelphia (Drug (SFA002) Vitamin D, Magnesium, Drug (SFA002) Vitamin D, Magnesium and Propionate)

    Recruiting
    • Psoriasis
    • Drug (SFA002) Vitamin D, Magnesium
    • Drug (SFA002) Vitamin D, Magnesium and Propionate
    • Fargo, North Dakota
    • +1 more
    Dec 9, 2022

    Peritoneal Malignant Mesothelioma Trial in United States (biological, drug, procedure)

    Recruiting
    • Peritoneal Malignant Mesothelioma
    • Atezolizumab
    • +8 more
    • Phoenix, Arizona
    • +25 more
    Feb 2, 2023

    Programmed Using Manifest Refraction Verses Using Phorcides

    Not yet recruiting
    • Myopia
    • Astigmatism
    • Contoura LASIK with Phorcides planning strategy
    • Contoura LASIK with manifest refraction planning strategy
    • Bismarck, North Dakota
      Bismarck Lasik
    May 25, 2023

    Assess the Reliability and Validity of the MLYMT

    Recruiting
    • Retinitis Pigmentosa
    • Retinal Dystrophy
    • Observational
    • Beverly Hills, California
    • +6 more
    Apr 18, 2023